Evaluation of the risk of malignancy index in preoperative diagnosis of ovarian masses

Royyuru Suchitra, Kaustubh Burde, Nilima G., P. L. S. Sahithi


Background: Ovarian cancer possesses a challenge to screening tests due to its anatomical location, poor natural history, lack of specific lesion, symptoms and signs and low prevalence. Authors shall be considering RMI 2 and RMI 4 (forms of RMI) and comparing them with histopathology report to derive the sensitivity, specificity and other parameters of these tests.

Methods: A prospective   study was conducted from September 2016- September 2017 at Mazumdar Shaw Hospital, Narayana Hrudayalaya, Bangalore.73 patients met the inclusion criteria. RMI 2   and RMI4 were calculated for all the patients and these scores were compared to the final histopathology reports.

Results: In present study of 73 patients RMI2 showed a sensitivity of 86.6%, specificity of 86.5 %, Positive predictive value of 81.25% and negative predictive value of 90.24 %. Whereas RMI4 showed a sensitivity of 86.6%, specificity of 86.5 %, Positive predictive value of 83.87 and negative predictive value of 90.48 %. These results are comparable to other studies conducted.  The risk of malignancy index 2 and 4 are also almost comparable with each other and so either can be used for determining the risk of malignancy in patients with adnexal masses. These results were derived in an Indian population across all age groups showing that authors can apply this low-cost method even in resource limited settings.

Conclusions: Authors found that Risk of malignancy index is a simple and affordable method to determine the likelihood of a patient having adnexal mass to be malignant. This can thus help save the resources and make the services available at grass root level.


Adnexal masses, CA 125, RMI2, RMI4, Screening

Full Text:



Hogg R, Friedlander M. Biology of epithelial ovarian cancer: Implications for screening women at high genetic risk. J Clin Oncol. 2004;22(7):1315-27.

Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A. Changing trends in incidence of ovarian cancer-the Indian scenario. Asian Pac J Cancer Prev. 2009;10(6):1025-30.

Takiar R, Nadayil D, Nandakumar A. Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pacific J Cancer Prev. 2010;11(4):1045-9.

Gangaraju S, Sarella LK, Chaveli L, Gurugubelli S. Scenario of ovarian mass lesions at a teaching hospital in Andhra Pradesh, India. Int J Reprod Contracept Obstet Gynecol. 2017;4(4):982-9.

Anton C, Carvalho FM, Oliveira EI, Maciel GA, Baracat EC, Carvalho JP. A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses. Clinics. 2012;67(5):437-41.

Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97:922-9.

Mohan L, Rao A, Ullal S, Krishna G. Accuracy of Pelvic Mass Score in Pre-operative Determination of Malignancy in Adnexal Masses. JCDR. 2016;10(11):QC01.

Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol. 1996;103(8):826-31.

Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Europ J Obstet Gynecol Reprod Biol. 2009;144(2):163-7.

Ozbay PO, Ekinci T, Çaltekin MD, Yilmaz HT, Temur M, Özgür Y, et al. Comparative evaluation of the risk of malignancy index scoring systems (1-4) used in differential diagnosis of adnexal masses. Asian Pacific J Cancer Prev. 2015;16(1):345-9.

Yamamoto Y, Tsuchida A, Ushiwaka T, Nagai R, Matsumoto M, Komatsu J, et al. Comparison of 4 risk-of-malignancy indexes in the preoperative evaluation of patients with pelvic masses: a prospective study. Clinical Ovarian Other Gynecol Cancer. 2014;7(1-2):8-12.

Aktürk E, Karaca RE, Alanbay İ, Dede M, Karaşahin E, Yenen MC, et al. Comparison of four malignancy risk indices in the detection of malignant ovarian masses. J Gynecol Oncol. 2011;22(3):177-82.

Insin P, Prueksaritanond N. Evaluation of Four Risk of Malignancy Indices (RMI) in the Preoperative Diagnosis of Ovarian Malignancy at Rajavithi Hospital. Rajavithi Hosp Thai J Obstet Gynaecol. 2013;21(21):163-75.

Karimi-Zarchi M, Mojaver SP, Rouhi M, Hekmatimoghaddam SH, Moghaddam RN, Yazdian-Anari P, et al. Diagnostic Value of the Risk of Malignancy Index (RMI) for Detection of Pelvic Malignancies Compared with Pathology. Elect Phys. 2015;7(7):1505-10.